CYBN 241220 22.50P (CYBN241220P22500) Stock Options, News & Quotes - Moomoo

US OptionsDetailed Quotes

CYBN241220P22500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 22 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
Moomoo NewsNov 19 07:33 ET · Ratings
Optimistic Buy Rating for Cybin: Promising CYB003 Phase 2 Results and Market Potential
TipRanksNov 19 06:56 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $190 Price Target
BenzingaNov 18 12:13 ET
Sector Update: Health Care Stocks Mixed Premarket Monday
MT NewswiresNov 18 09:19 ET
Cybin Says Phase 2 Data Show Potential Depression Drug Offers Relief Through 1 Year
MT NewswiresNov 18 08:09 ET
Express News | Cybin Inc - Initiates Phase 3 Paradigm Program for Cyb003
ReutersNov 18 07:01 ET

Comments

$Cybin (CYBN.US)$ buying more now 🖕

1

$Cybin (CYBN.US)$👀 more news out on trials 100% effectiveness so far on the therapy drug for treating depression
CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
trading under 12 now seems like something is in the works.
$Vertex Pharmaceuticals (VRTX.US)$ $Astera Labs (ALAB.US)$ $Emergent BioSolutions (EBS.US)$

$Cybin (CYBN.US)$ break the downward wedge LFG 🐂💥🚀

2

$Cybin (CYBN.US)$ say what ??? 🤣
$NVIDIA (NVDA.US)$ $Tesla (TSLA.US)$ $SoFi Technologies (SOFI.US)$

1

1

$Cybin (CYBN.US)$ i suppose the good news is reason to sell

Read more